African-Americans have unique lung cancer risks

Scientists have developed a risk prediction assessment for lung cancer specifically for African Americans that suggests a greater risk from chronic obstructive pulmonary disease (COPD).

Gene Can Predict Lung Cancer Survival

Gene expression test could help determine who needs more aggressive lung cancer treatment.

Gene Test May Change Treatment, Extend Life For Lung Cancer Patients

Researchers have shown that a readily available gene screening test can help doctors know which people with advanced non-small-cell lung cancer will benefit from adding a second cancer drug to standard chemotherapy.

CTC Chip Tracks Lung Cancer Cells

New technique makes it possible to identify genetic fingerprint of lung cancer cells. Circulating tumor cells (CTC) will help doctors to identify cancer cell mutations, choose targeted therapies for each patient individually, track cancer cell changes during treatment and change it if necessary.

Have You Exercised Your Lungs Today?

The Expand-A-Lung Breathing Resistance Exerciser has been selected as the top choice for respiratory fitness training by LA Times. Jorge Brouwer, inventor of the most compact breathing exerciser, manufactures and markets the easy to use "Expand-A-Lung."

Researchers Find Key Developmental Pathway Activates Lung Stem Cells

Researchers found that the activation of a molecular pathway important in stem cell and developmental biology leads to an increase in lung stem cells.

Looking At Lung Cancer And Tobacco Carcinogens

Two types of cancer-causing agents in cigarettes - a nicotine-derived chemical and polycyclic aromatic hydrocarbons (PAHs) are the main culprits in lung cancer.

ALIMTA Improves Survival In Non-Small Cell Lung Cancer

The type of non-small cell lung cancer (NSCLC) patients have may now influence their treatment regimen and, in turn, survival outcome.

AT Gene Deficiency Increases Lung Cancer Risk

A study links lung cancer to a certain gene variation - alpha1-antitrypsin gene deficiency, which increases the risk for developing lung cancer.

Determining Genetic Signature Of Lung Tumors Can Help Guide Treatment

While a previous study found that upfront gefitinib treatment considerably improved the outcomes for non-small-cell-lung-cancer, additional research is required before such a strategy can be used for routine treatment planning.

Lung Cancer Symptoms and Treatment